A citation-based method for searching scientific literature

Dorit Trudler, Swagata Ghatak, Stuart A Lipton. Int J Mol Sci 2021
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening.
Paz Ovics, Danielle Regev, Polina Baskin, Mor Davidor, Yuval Shemer, Shunit Neeman, Yael Ben-Haim, Ofer Binah. Int J Mol Sci 2020
6
50

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates.
Suzan J G Knottnerus, Isabella Mengarelli, Rob C I Wüst, Antonius Baartscheer, Jeannette C Bleeker, Ruben Coronel, Sacha Ferdinandusse, Kaomei Guan, Lodewijk IJlst, Wener Li,[...]. Int J Mol Sci 2020
12
50

Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
Juan Antonio Garcia-Leon, Laura Caceres-Palomo, Elisabeth Sanchez-Mejias, Marina Mejias-Ortega, Cristina Nuñez-Diaz, Juan Jose Fernandez-Valenzuela, Raquel Sanchez-Varo, Jose Carlos Davila, Javier Vitorica, Antonia Gutierrez. Int J Mol Sci 2020
12
50

Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients.
Stefan Bräuer, René Günther, Jared Sterneckert, Hannes Glaß, Andreas Hermann. Int J Mol Sci 2020
5
50

Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1.
Christin Völkner, Maik Liedtke, Andreas Hermann, Moritz J Frech. Int J Mol Sci 2021
4
50



Interactome Analysis of iPSC Secretome and Its Effect on Macrophages In Vitro.
Luca Tamò, Kleanthis Fytianos, Fabienne Caldana, Cedric Simillion, Anis Feki, Izabela Nita, Manfred Heller, Thomas Geiser, Amiq Gazdhar. Int J Mol Sci 2021
3
50

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson's Disease for Drug Identification.
Georgia Kouroupi, Nasia Antoniou, Kanella Prodromidou, Era Taoufik, Rebecca Matsas. Int J Mol Sci 2020
4
50

Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.
Chun Liu, Angelos Oikonomopoulos, Nazish Sayed, Joseph C Wu. Development 2018
103
50

Antioxidant Amelioration of Riboflavin Transporter Deficiency in Motoneurons Derived from Patient-Specific Induced Pluripotent Stem Cells.
Chiara Marioli, Valentina Magliocca, Stefania Petrini, Alessia Niceforo, Rossella Borghi, Sara Petrillo, Piergiorgio La Rosa, Fiorella Colasuonno, Tiziana Persichini, Fiorella Piemonte,[...]. Int J Mol Sci 2020
4
50

Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic Acidemia.
Esmeralda Alonso-Barroso, Belén Pérez, Lourdes Ruiz Desviat, Eva Richard. Int J Mol Sci 2021
2
50

iPSC-Derived Microglia for Modeling Human-Specific DAMP and PAMP Responses in the Context of Alzheimer's Disease.
Ivanna Ihnatovych, Barbara Birkaya, Emily Notari, Kinga Szigeti. Int J Mol Sci 2020
1
100

Induced Pluripotency: A Powerful Tool for In Vitro Modeling.
Romana Zahumenska, Vladimir Nosal, Marek Smolar, Terezia Okajcekova, Henrieta Skovierova, Jan Strnadel, Erika Halasova. Int J Mol Sci 2020
6
50

Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression.
Janik Böhnke, Sandra Pinkert, Maria Schmidt, Hans Binder, Nicole Christin Bilz, Matthias Jung, Uta Reibetanz, Antje Beling, Dan Rujescu, Claudia Claus. Int J Mol Sci 2021
1
100

Human iPSC-Derived 2D and 3D Platforms for Rapidly Assessing Developmental, Functional, and Terminal Toxicities in Neural Cells.
Ileana Slavin, Steven Dea, Priyanka Arunkumar, Neha Sodhi, Sandro Montefusco, Jair Siqueira-Neto, Janet Seelke, Mary Anne Lofstrom, Blake Anson, Fabian Zanella,[...]. Int J Mol Sci 2021
2
50

Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Soo-Hyeon Yun, Ha-Hyeon Shin, Eun-Seon Ju, You-Jung Lee, Byung-Kwan Lim, Eun-Seok Jeon. Int J Mol Sci 2020
4
50


Robust and Scalable Angiogenesis Assay of Perfused 3D Human iPSC-Derived Endothelium for Anti-Angiogenic Drug Screening.
Vincent van Duinen, Wendy Stam, Eva Mulder, Farbod Famili, Arie Reijerkerk, Paul Vulto, Thomas Hankemeier, Anton Jan van Zonneveld. Int J Mol Sci 2020
5
50

hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery.
Junjun Li, Ying Hua, Shigeru Miyagawa, Jingbo Zhang, Lingjun Li, Li Liu, Yoshiki Sawa. Int J Mol Sci 2020
6
50

Human Embryo Models and Drug Discovery.
Margit Rosner, Manuel Reithofer, Dieter Fink, Markus Hengstschläger. Int J Mol Sci 2021
2
50

Gene Editing Correction of a Urea Cycle Defect in Organoid Stem Cell Derived Hepatocyte-like Cells.
Mihaela Zabulica, Tomas Jakobsson, Francesco Ravaioli, Massoud Vosough, Roberto Gramignoli, Ewa Ellis, Olav Rooyackers, Stephen C Strom. Int J Mol Sci 2021
6
50



Improving efficiency of ALS clinical trials using lead-in designs.
Dan H Moore, Robert G Miller. Amyotroph Lateral Scler Other Motor Neuron Disord 2004
16
50

Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain.
Xiaoying Zhuang, Xiaoyu Xiang, William Grizzle, Dongmei Sun, Shuangqin Zhang, Robert C Axtell, Songwen Ju, Jiangyao Mu, Lifeng Zhang, Lawrence Steinman,[...]. Mol Ther 2011
682
50

Vitamin E intake and risk of amyotrophic lateral sclerosis.
Alberto Ascherio, Marc G Weisskopf, Eilis J O'reilly, Eric J Jacobs, Marjorie L McCullough, Eugenia E Calle, Merit Cudkowicz, Michael J Thun. Ann Neurol 2005
109
50

S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis.
Richard J Mead, Adrian Higginbottom, Scott P Allen, Janine Kirby, Ellen Bennett, Siân C Barber, Paul R Heath, Antonio Coluccia, Neelam Patel, Iain Gardner,[...]. Free Radic Biol Med 2013
43
50

Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
Yu-Ichi Noto, Kazumoto Shibuya, Steve Vucic, Matthew C Kiernan. Expert Rev Neurother 2016
11
50


Modeling ALS using iPSCs: is it possible to reproduce the phenotypic variations observed in patients in vitro?
Juliana Ferreira Vasques, Rosalia Mendez-Otero, Fernanda Gubert. Regen Med 2020
1
100

Prospective study of cigarette smoking and amyotrophic lateral sclerosis.
M G Weisskopf, M L McCullough, E E Calle, M J Thun, M Cudkowicz, A Ascherio. Am J Epidemiol 2004
101
50

Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date.
Ivana Štětkářová, Edvard Ehler. Diagnostics (Basel) 2021
4
50

Detection of BMAA in the human central nervous system.
L Berntzon, L O Ronnevi, B Bergman, J Eriksson. Neuroscience 2015
33
50

Novel nanogels as drug delivery systems for poorly soluble anticancer drugs.
Na Li, Jinli Wang, Xingguo Yang, Lingbing Li. Colloids Surf B Biointerfaces 2011
26
50

Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics.
Jarosław Walczak, Grażyna Dębska-Vielhaber, Stefan Vielhaber, Jędrzej Szymański, Agata Charzyńska, Jerzy Duszyński, Joanna Szczepanowska. FASEB J 2019
12
50

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
M E Gurney, F B Cutting, P Zhai, A Doble, C P Taylor, P K Andrus, E D Hall. Ann Neurol 1996
534
50

Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis.
Mireia Herrando-Grabulosa, Núria Gaja-Capdevila, José M Vela, Xavier Navarro. Br J Pharmacol 2021
13
50

The overlap of amyotrophic lateral sclerosis and frontotemporal dementia.
Catherine Lomen-Hoerth, Thomas Anderson, Bruce Miller. Neurology 2002
477
50

Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
Weihua Zhao, David R Beers, Stanley H Appel. J Neuroimmune Pharmacol 2013
182
50

Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain.
Yuko Takayasu, Junko Nakaki, Toshiyuki Kawasaki, Ken Koda, Yukio Ago, Akemichi Baba, Toshio Matsuda. J Pharmacol Sci 2007
26
50

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Manuela Neumann, Deepak M Sampathu, Linda K Kwong, Adam C Truax, Matthew C Micsenyi, Thomas T Chou, Jennifer Bruce, Theresa Schuck, Murray Grossman, Christopher M Clark,[...]. Science 2006
50

The natural history of primary lateral sclerosis.
P H Gordon, B Cheng, I B Katz, M Pinto, A P Hays, H Mitsumoto, L P Rowland. Neurology 2006
221
50

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.
Melanie D Sweeney, Abhay P Sagare, Berislav V Zlokovic. Nat Rev Neurol 2018
761
50

Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS.
Wenhua Zhang, Malini Narayanan, Robert M Friedlander. Ann Neurol 2003
145
50

Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis.
Thomas J Lukas, Wei Wei Luo, Haihong Mao, Natalie Cole, Teepu Siddique. Mol Cell Proteomics 2006
30
50

Electrospinning Nanofibers for Therapeutics Delivery.
S M Shatil Shahriar, Jagannath Mondal, Mohammad Nazmul Hasan, Vishnu Revuri, Dong Yun Lee, Yong-Kyu Lee. Nanomaterials (Basel) 2019
53
50

Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.
Jochen H Weishaupt, Claudia Bartels, Esther Pölking, Jeannine Dietrich, Gundula Rohde, Burkhard Poeggeler, Nina Mertens, Swetlana Sperling, Matthias Bohn, Gerald Hüther,[...]. J Pineal Res 2006
168
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.